April Price Cuts Drive S. Korean Drug Makers To Look Abroad For Survival
This article was originally published in PharmAsia News
Government-ordered price cuts for drugs are leading many local pharmaceutical companies to look more seriously toward the international market as saviors as well as competitors.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.